DOI:
10.1055/s-00000071
Seminars in Neurology
LinksClose Window
References
Kuesters G, Plavina T, Lee S , et al.
Anti-JC virus (JCV) antibody index differentiates risk of progressive multifocal leukoencephalopathy in natalizumab-treated multiple sclerosis patients with no prior immunosuppressant use: an updated analysis.
Poster presented at: 67th American Academy of Neurology Annual Meeting; April 18–15, 2015; Washington, DC
We do not assume any responsibility for the contents of the web pages of other providers.